Stock DRMA DERMATA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Dermata Therapeutics, Inc.

Equities

DRMA

US2498454055

Delayed Nasdaq
Other stock markets
 11:34:24 26/06/2024 pm IST 		5-day change 1st Jan Change
2.65 USD -2.57% Intraday chart for Dermata Therapeutics, Inc. +10.88% -71.04%
15/05 Dermata Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/03 Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dermata Therapeutics, Inc Promotes Christopher J. Nardo as Senior Vice President, Chief Development Officer, Effective July 1, 2022
CI
Dermata Therapeutics, Inc. Announces Board Changes
CI
Dermata Therapeutics, Inc. Appoints Kyri Van Hoose as Senior Vice President
CI
Dermata Therapeutics : Names New CFO
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRMA Stock
  4. News Dermata Therapeutics, Inc.
  5. Insiders